AMT
42
-5
BRK.B
45
-2
DE
32
-4
BK
66
-3
FE
48
-2
CAT
62
-4
UAL
53
-5
TGNA
45
-3
ILMN
37
-5
MAC
47
-18
TRIP
67
-8
ISRG
67
-2
AKAM
45
-3
FCX
54
-7
OKE
64
-7
PHM
69
-2
HPE
16
-5
GD
62
-2
M
40
-2
TEL
71
-6
AMT
42
-5
BRK.B
45
-2
DE
32
-4
BK
66
-3
FE
48
-2
CAT
62
-4
UAL
53
-5
TGNA
45
-3
ILMN
37
-5
MAC
47
-18
TRIP
67
-8
ISRG
67
-2
AKAM
45
-3
FCX
54
-7
OKE
64
-7
PHM
69
-2
HPE
16
-5
GD
62
-2
M
40
-2
TEL
71
-6
Financhill
Back

Fate Therapeutics Vs. Amicus Therapeutics Industry Stock Comparison

Sell
24

FATE
Fate Therapeutics

Last Price:
4.08
Seasonality Move:
-2.97%
Sell
22

FOLD
Amicus Therapeutics

Last Price:
10.42
Seasonality Move:
19.73%
Sell
24
Fate Therapeutics (FATE) is a Sell

Is Fate Therapeutics a Buy, Sell or Hold?

  • The current Fate Therapeutics [FATE] share price is $3.95. The Score for FATE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • FATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.99. The Score for FOLD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FATE Stock Price Chart

What is Fate Therapeutics's stock price today?

  • The Fate Therapeutics share price today is $3.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing selling pressure, which indicates risk of future bearish movement.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.

FATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 23.81 Sell
Chaikin Money Flow: -1996012 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.53 - 6.93) Sell
Bollinger Bands (100): (3.86 - 7.16) Sell

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 30.12 Sell
Chaikin Money Flow: -1529368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.41 - 11.57) Sell
Bollinger Bands (100): (11.25 - 13.49) Sell

FATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.26 Sell
20-day SMA: 5.39 Sell
50-day SMA: 6.52 Sell
200-day SMA: 4.07 Sell
8-day EMA: 4.31 Sell
20-day EMA: 5.13 Sell
50-day EMA: 5.77 Sell
200-day EMA: 5.73 Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.42 Sell
20-day SMA: 10.83 Sell
50-day SMA: 11.77 Sell
200-day SMA: 12.18 Sell
8-day EMA: 10.35 Sell
20-day EMA: 10.76 Sell
50-day EMA: 11.45 Sell
200-day EMA: 11.99 Sell

Fate Therapeutics Earnings Growth & FATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.50 per share, and an increase next year of $0.38 per share.

Fate Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):